default author photo

Takafumi Ikeda

Kyoto University - Institute for Advancement of Clinical and Translational Science

Kyoto

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

210

TOTAL CITATIONS

1

Scholarly Papers (1)

Safety and Effectiveness of a Novel Neuroprotectant, KUS121, in Patients with Non-Arteritic Central Retinal Artery Occlusion: An Open-Label, Non-Randomized, First-in-Humans Phase 1/2 Trial

Number of pages: 38 Posted: 25 Feb 2019
Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Department of Biomedical Statistics and Bioinformatics, Kyoto University - Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto University - Department of Ophthalmology and Visual Sciences and Kyoto University - Department of Ophthalmology and Visual Sciences
Downloads 80 (812,480)

Abstract:

Loading...

neuroprotection; central retinal artery occlusion; first-inhumans clinical trial; best-corrected visual acuity

Safety and Effectiveness of a Novel Neuroprotectant, KUS121, in Patients with Non-Arteritic Central Retinal Artery Occlusion: An Open-Label, Non-Randomized, First-in-Humans Phase 1/2 Trial

Number of pages: 40 Posted: 08 Apr 2019
Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Department of Biomedical Statistics and Bioinformatics, Kyoto University - Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto University - Department of Ophthalmology and Visual Sciences and Kyoto University - Department of Ophthalmology and Visual Sciences
Downloads 75 (848,302)
Citation 1

Abstract:

Loading...

neuroprotection; central retinal artery occlusion; first-inhumans clinical trial; best-corrected visual acuity

Safety and Effectiveness of a Novel Neuroprotectant, KUS121, in Patients with Non-Arteritic Central Retinal Artery Occlusion: An Open-Label, Non-Randomized, First-in-Humans Phase 1/2 Trial

Number of pages: 40 Posted: 13 Dec 2018
Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Department of Ophthalmology and Visual Sciences, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Institute for Advancement of Clinical and Translational Science, Kyoto University - Department of Biomedical Statistics and Bioinformatics, Kyoto University - Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto University - Department of Ophthalmology and Visual Sciences and Kyoto University - Department of Ophthalmology and Visual Sciences
Downloads 55 (1,027,773)

Abstract:

Loading...